Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Jabil | JBL | Apr 25, 2024 | 118.48 | -1.46 |
Jack Henry & Associates | JKHY | Apr 25, 2024 | 165.89 | +0.42 |
Jack In The Box | JACK | Apr 25, 2024 | 58.44 | -0.70 |
Jackson Financial | JXN | Apr 25, 2024 | 69.58 | -1.44 |
Jackson Financial | JXN-A | Apr 25, 2024 | 25.92 | -0.96 |
Jacobs Engineering Group | J | Apr 25, 2024 | 144.18 | +0.14 |
Jaguar Health | JAGX | Apr 25, 2024 | 0.17 | +0.06 |
JAKKS Pacific | JAKK | Apr 25, 2024 | 19.73 | -15.90 |
James Hardie Industries ADR | JHX | Apr 25, 2024 | 34.95 | -0.63 |
James River Group Holdings | JRVR | Apr 25, 2024 | 9.16 | -1.29 |
Jamf | JAMF | Apr 25, 2024 | 19.15 | -2.54 |
JanOne | JAN | Apr 25, 2024 | 4.71 | -1.46 |
Janover | JNVR | Apr 25, 2024 | 1.03 | -3.73 |
Janus Henderson Group | JHG | Apr 25, 2024 | 31.28 | -1.08 |
Janus International Group | JBI | Apr 25, 2024 | 14.48 | -3.92 |
Janus Small Cap Growth Alpha ETF | JSML | Apr 25, 2024 | 57.27 | -0.88 |
Janus Small/Mid Cap Growth Alpha ETF | JSMD | Apr 25, 2024 | 66.61 | -0.33 |
Janux Therapeutics | JANX | Apr 25, 2024 | 47.10 | -2.30 |
Japan Alphadex First Trust | FJP | Apr 25, 2024 | 51.40 | -2.41 |
Japan Hedged Equity Wisdomtree | DXJ | Apr 25, 2024 | 105.63 | -1.52 |
Japan Index MSCI Ishares | EWJ | Apr 25, 2024 | 66.56 | -1.55 |
Japan Smallcap Dividend Wisdomtree | DFJ | Apr 25, 2024 | 73.81 | -1.34 |
Japan Smallcap Index MSCI Ishares | SCJ | Apr 25, 2024 | 71.20 | -1.45 |
Japan Smaller Capitalization Fund | JOF | Apr 25, 2024 | 7.59 | -0.78 |
Japanese Yen Trust | FXY | Apr 25, 2024 | 59.51 | -0.23 |
Jasper Therapeutics A | JSPR | Apr 25, 2024 | 21.18 | -3.86 |
Jaws Mustang Acquisition A | JWSM | Apr 25, 2024 | 11.00 | -0.18 |
Jayud Global Logistics | JYD | Apr 25, 2024 | 0.91 | +0.05 |
Jazz Pharmaceuticals | JAZZ | Apr 25, 2024 | 107.43 | -0.82 |
JBG Smith Properties | JBGS | Apr 25, 2024 | 15.09 | -1.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.